antiplatelet therapy - Robuta Search

https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.1081934/full Frontiers | Antiplatelet therapy in patients with myocardial infarction with non-obstructive... AbstractMyocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogeneous group of diseases with different pathological mechanisms, an... antiplatelet therapy in patients myocardial infarction frontiers non https://www.aafp.org/afp/2017/1001/od1 Prolonged Dual Antiplatelet Therapy After MI Reduces Major Adverse Cardiac Events | AFP In patients who are stable one year post-MI, prolonged use of dual antiplatelet therapy may be an effective treatment to decrease major cardiac events and... major adverse cardiac events dual antiplatelet therapy https://www.miragenews.com/dual-antiplatelet-therapy-cut-benefits-post-cabg-1528221/ Dual Antiplatelet Therapy Cut Benefits Post-CABG | Mirage News Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and reduced clinically relevant dual antiplatelet therapy cut benefits post cabg https://www.aafp.org/pubs/afp/issues/2022/1200/cochrane-antiplatelet-therapy-chronic-kidney-disease.html Antiplatelet Therapy in Chronic Kidney Disease | AAFP Does antiplatelet therapy prevent myocardial infarction in patients with chronic kidney disease (CKD)? chronic kidney disease antiplatelet therapy aafp https://www.aafp.org/pubs/afp/issues/2019/1015/p463.html Dual Antiplatelet Therapy for Patients with Cardiovascular Disease | AAFP Patients with established cardiovascular disease or risk factors (e.g., ischemic cerebrovascular disease, peripheral arterial disease, high risk of... dual antiplatelet therapy for patients cardiovascular disease aafp https://www.acc.org/Latest-in-Cardiology/Articles/2025/12/08/18/14/Demystifying-Antiplatelet-Therapy Demystifying Antiplatelet Therapy Duration Following Percutaneous Coronary Intervention - American... antiplatelet therapy demystifying duration following percutaneous https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.762391/full Frontiers | Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon The drug-coated balloon (DCB) is an emerging percutaneous coronary intervention device with theoretical advantages and promising results. Recent clinical obs... dual antiplatelet therapy frontiers duration https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1533674/full Frontiers | New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke... Background and purposeThe objective of this study is to systematically review the efficacy and safety of cilostazol-based dual antiplatelet therapy (DAPT) in... dual antiplatelet therapy new options frontiers cilostazol https://www.cochrane.org/evidence/CD001342_vitamin-k-antagonists-versus-antiplatelet-therapy-after-transient-ischaemic-attack-or-minor Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor... vitamin k antagonists transient ischaemic attack antiplatelet therapy https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/01/10/13/55/inspires Intensive Statin and Antiplatelet Therapy for Acute High-Risk Intracranial or Extracranial... antiplatelet therapy https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2018/04/17/14/52/Genotype-Guided-Antiplatelet-Therapy-After-PCI Genotype-Guided Antiplatelet Therapy After PCI - American College of Cardiology Sherrie R. Webb, PA-C antiplatelet therapy american college genotype guided pci https://www.hematology.org/about/history/50-years/antiplatelet-therapy Antiplatelet Therapy - Hematology.org Antiplatelet Therapy antiplatelet therapy hematology https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/03/15/14/01/clinical-impact-of-CYP2C19 CYP2C19-Guided Antiplatelet Therapy After PCI - American College of Cardiology Bina Ahmed, MD, FACC antiplatelet therapy american college cyp2c19 guided pci https://www.cochrane.org/evidence/CD000029_oral-antiplatelet-therapy-acute-ischaemic-stroke Oral antiplatelet therapy for acute ischaemic stroke | Cochrane antiplatelet therapy ischaemic stroke oral acute cochrane https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2013/07/08/16/28/ARMYDA-8-RELOAD-ACS Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty - American College of... antiplatelet therapy reduction https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2010/02/23/18/55/ARMYDA4--Presented-at-TCT-2007 Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 4 - American College of... antiplatelet therapy https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.954704/full Frontiers | Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients... Background Optimal duration of dual antiplatelet therapy (DAPT) in patients with diabetes mellitus (DM) who have undergone drug-eluting stent (DES) implantat... dual antiplatelet therapy drug eluting stent https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2020/12/21/18/20/Short-Dual-Antiplatelet-Therapy Shorter vs. Longer Duration of Antiplatelet Therapy After PCI - American College of Cardiology Bina Ahmed, MD, FACC antiplatelet therapy https://www.acc.org/latest-in-cardiology/clinical-trials/2018/03/09/08/30/adapt-pci Assessment of prospective emCYP2C19/em genotype guided Dosing of AntiPlatelet Therapy in... Dharam J. Kumbhani, MD, SM, FACC antiplatelet therapy assessment prospective em https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2021.652579/full Frontiers | MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review MicroRNAs (miRNAs) are small, noncoding RNAs, able to regulate cellular functions by specificgene modifications. Platelets are the major source for circulati... https://pmc.ncbi.nlm.nih.gov/articles/PMC11607341/ Incidence and prognosis of first-ever intracerebral hemorrhage on antiplatelet therapy over 10... The use of antiplatelet therapy (APT) is prevalent among the general population, sometimes without clear indications. We provided updated figures on the... https://www.anticoagulationeurope.org/ Anticoagulation Therapy | Antiplatelet Therapy | Support and Information anticoagulation therapy antiplatelet support information